<b>Diroximel fumarate acts through Nrf2 to attenuate methylglyoxal-induced nociception in mice and decrease ISR activation in DRG neurons</b> by Muhammad Saad Yousuf (20745168)

Effects of TGF-β1 on the expression of fibrosis indicators in HBdSMCs and the effects of MEL on the expression of fibrosis indicators in HBdSMCs induced by TGF-β1. by Yang Zhang (30734)

Antibodies used for flow cytometry experiments. by Joseph Rabin (7399436)

“…RA was devoid of serious side effects, and within 24 hours from the start of infusion was associated with increased oxygen saturation (93.8 ± 0.58 vs 96.6 ± 1.08%, P<0.05), decreased D-dimer (754 ± 17 vs 518 ± 98 ng/ml, P<0.05), and a trend toward decreased CRP (3.80 ± 1.40 vs 1.98 ± 0.74 mg/dL, P = 0.075). …”

Subject flow diagram. by Joseph Rabin (7399436)

“…RA was devoid of serious side effects, and within 24 hours from the start of infusion was associated with increased oxygen saturation (93.8 ± 0.58 vs 96.6 ± 1.08%, P<0.05), decreased D-dimer (754 ± 17 vs 518 ± 98 ng/ml, P<0.05), and a trend toward decreased CRP (3.80 ± 1.40 vs 1.98 ± 0.74 mg/dL, P = 0.075). …”

Supplementary Material for: Ectopic ACTH-dependent Cushing’s syndrome Emerging at a Late Stage of a Mixed Histology Neuroendocrine Neoplasm: a case report by Meyers M. (19672471)

Table_1_The Metabolic Changes and Immune Profiles in Patients With COVID-19.pdf by Bing He (135034)

“…In the late stage of COVID-19, severe cases had extremely low CD4⁺ T cells and CD8⁺ T cells, but unusually high neutrophils [6.5 × 10⁹/L (IQR, 4.8–9.6)], procalcitonin [0.27 ng/mL (IQR, 0.14–1.94)], C-reactive protein [66 mg/L (IQR, 25–114)] and an extremely high level of interleukin-6. …”

Data_Sheet_4_Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.DOC by Xudong Feng (1426792)

“…In addition, the WBC count>10 × 10⁹/L, lymphocyte count<1 × 10⁹/L, PCT>0.5 ng/mL, and CRP>10 mg/L were risk factors for disease progression in patients with COVID-19 (WBC count>10 × 10⁹/L: OR = 2.92, 95% CI: 1.96–4.35; lymphocyte count<1 × 10⁹/L: OR = 4.97, 95% CI: 3.53–6.99; PCT>0.5 ng/mL: OR = 6.33, 95% CI: 3.97–10.10; CRP>10 mg/L: OR = 3.51, 95% CI: 2.38–5.16). …”

Data_Sheet_1_Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.DOC by Xudong Feng (1426792)

“…In addition, the WBC count>10 × 10⁹/L, lymphocyte count<1 × 10⁹/L, PCT>0.5 ng/mL, and CRP>10 mg/L were risk factors for disease progression in patients with COVID-19 (WBC count>10 × 10⁹/L: OR = 2.92, 95% CI: 1.96–4.35; lymphocyte count<1 × 10⁹/L: OR = 4.97, 95% CI: 3.53–6.99; PCT>0.5 ng/mL: OR = 6.33, 95% CI: 3.97–10.10; CRP>10 mg/L: OR = 3.51, 95% CI: 2.38–5.16). …”

Data_Sheet_3_Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.DOCX by Xudong Feng (1426792)

“…In addition, the WBC count>10 × 10⁹/L, lymphocyte count<1 × 10⁹/L, PCT>0.5 ng/mL, and CRP>10 mg/L were risk factors for disease progression in patients with COVID-19 (WBC count>10 × 10⁹/L: OR = 2.92, 95% CI: 1.96–4.35; lymphocyte count<1 × 10⁹/L: OR = 4.97, 95% CI: 3.53–6.99; PCT>0.5 ng/mL: OR = 6.33, 95% CI: 3.97–10.10; CRP>10 mg/L: OR = 3.51, 95% CI: 2.38–5.16). …”

Data_Sheet_2_Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.DOC by Xudong Feng (1426792)

“…In addition, the WBC count>10 × 10⁹/L, lymphocyte count<1 × 10⁹/L, PCT>0.5 ng/mL, and CRP>10 mg/L were risk factors for disease progression in patients with COVID-19 (WBC count>10 × 10⁹/L: OR = 2.92, 95% CI: 1.96–4.35; lymphocyte count<1 × 10⁹/L: OR = 4.97, 95% CI: 3.53–6.99; PCT>0.5 ng/mL: OR = 6.33, 95% CI: 3.97–10.10; CRP>10 mg/L: OR = 3.51, 95% CI: 2.38–5.16). …”

Supplementary Material for: The Effect of The Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes A Study by the Israeli... by Merkel D. (17648583)

Minimum concentration of Amphotericin B in serum according to the formulation, dose, and daily or prolonged intermittent therapeutic regimen by Leticia Aparecida Schiave (8438409)

“…The geometric mean Cmin tended to decrease with a reduction in the dose and frequency of intermittent L-AmB infusions: 357 ng/mL (100 mg 4 to 5 times/week) > 263 ng/mL (50 mg 4 to 5 times/week) > 227 ng/mL (50 mg 1 to 3 times/week). …”

High-Throughput Absolute mRNA Quantification Using Real-time RT-PCR by Anthony J Bais (13285305)

“…A reaction mix for 1 ug of amplicon cDNA contained 10 ul of 10x PCR buffer (containing 15 mM MgCl2), 2 ul of 10 mM dNTP mix, 0.5 uM of each primer, 0.5 ul of 2.5 U HotStar-Taq polymerase (Qiagen), 100 ng of cDNA template and water to 100 ul. …”

Supplementary Material for: ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients by Karakike E. (11776763)

Image1_Ethyl 2-Succinate-Anthraquinone Attenuates Inflammatory Response and Oxidative Stress via Regulating NLRP3 Signaling Pathway.TIF by Burong Feng (11661529)

“…In vivo, we revealed that the LHD, in different doses (6.25 mg/kg, 12.5 mg/kg, 25 mg/kg, 50 mg/kg), has a protective effect on stress physiological responses by assessing the body temperature of mice. …”

Image2_Ethyl 2-Succinate-Anthraquinone Attenuates Inflammatory Response and Oxidative Stress via Regulating NLRP3 Signaling Pathway.TIF by Burong Feng (11661529)

“…In vivo, we revealed that the LHD, in different doses (6.25 mg/kg, 12.5 mg/kg, 25 mg/kg, 50 mg/kg), has a protective effect on stress physiological responses by assessing the body temperature of mice. …”

Aucubin slows the development of osteoporosis by inhibiting osteoclast differentiation via the nuclear factor erythroid 2-related factor 2-mediated antioxidation pathway by Yongfeng Zhang (5963987)

“…The administration lasted for 7 weeks. Subsequently, 1, 2.5 and 5 µM AU were incubated with 50 ng/mL RANKL-induced RAW264.7 cells for 7 days to observe osteoclast differentiation. …”